Clinical Trials Logo

Enterocolitis, Necrotizing clinical trials

View clinical trials related to Enterocolitis, Necrotizing.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06422988 Enrolling by invitation - Clinical trials for Enterocolitis, Necrotizing

Do Probiotics Reduce The Risk Of Severe Necrotising Enterocolitis (NEC) In Infants Born Before 32 Weeks Gestation?

Start date: May 30, 2024
Phase:
Study type: Observational

Necrotising enterocolitis (NEC) is one of the leading causes of mortality and morbidity in very preterm infants. This study aims to determine whether NEC rates are different between infants who receive probiotics versus infants who do not receive probiotics. The study has a retrospective cohort design and will utilise routinely collected data from the UK National Neonatal Research Database (NNRD). The cohort will comprise all infants born before 32 weeks gestation and cared for in neonatal units in England and Wales between 2016 and 2022. A propensity score matched approach will be used to conduct two comparisons: i) the risk of necrotising enterocolitis (NEC) between who do and those who do not receive probiotics in the first 14 days of life ii) the risk of NEC between babies who receive the two most common probiotic products used in UK units, (Labinic and Proprems).

NCT ID: NCT02050971 Enrolling by invitation - Clinical trials for Bronchopulmonary Dysplasia

Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates

Start date: October 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the safety and effectiveness of a whole own (autologous) umbilical cord blood transfusion in the first 5 days after birth if the baby is born premature <34 weeks and developed anemia of prematurity.